Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473784 · ClinicalTrials.gov registry record · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
A NA study of Recurrent Adenoid Cystic Carcinoma of the Oral Cavity and Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT01473784: Recruiting NA study of Recurrent Adenoid Cystic Carcinoma of the Oral Cavity and Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01473784 is a NA study of Recurrent Adenoid Cystic Carcinoma of the Oral Cavity and Recurrent Mucoepidermoid Carcinoma of the Oral Cavity that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 600 participants, above the 27-participant average among 3 other Recurrent Adenoid Cystic Carcinoma of the Oral Cavity trials with a reported enrollment target (2122% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473784, a NA study of Recurrent Adenoid Cystic Carcinoma of the Oral Cavity and Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies transoral robotic surgery (TORS) in treating patients with benign or malignant tumors of the head and neck. TORS is a less invasive type of surgery for head and neck cancer and may have fewer side effects and improve recovery
Conditions Studied
Interventions
- PROCEDURE transoral robotic surgery
- PROCEDURE quality of life assessment
Study Locations (1)
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2007-12-03 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT01473784 shows while recruiting
NCT01473784 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 27-participant average among 3 other Recurrent Adenoid Cystic Carcinoma of the Oral Cavity trials with a reported enrollment target (2122% higher).
The record links to 10 conditions, with Recurrent Adenoid Cystic Carcinoma of the Oral Cavity appearing as the primary indexed condition, and to 2 interventions - of which transoral robotic surgery is the first listed.
NCT01473784 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01473784 about?
NCT01473784 is a clinical study titled "Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck". This pilot clinical trial studies transoral robotic surgery (TORS) in treating patients with benign or malignant tumors of the head and neck. TORS is a less invasive type of surgery for head and neck cancer and may have fewer side effects and improve recovery
What is the current status of trial NCT01473784?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2007-12-03. Estimated completion is 2026-12-31.
What conditions does trial NCT01473784 study?
This clinical trial studies the following conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity.
What interventions are being tested in trial NCT01473784?
The interventions under investigation include: transoral robotic surgery (PROCEDURE), quality of life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT01473784?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01473784 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
COMPLETED · Phase 1
-
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
COMPLETED · Phase 1
-
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
- NCT02050113 · 600 participants · NA
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI